Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

Completed · Phase 4 · Has a placebo group

Conditions studied: Hypertension

In brief

The purpose of this study is to assess the efficacy, safety, and tolerability of 8 weeks of therapy with nebivolol in comparison to placebo in younger patients 18 - 54 years of age with stage 1 or stage 2 essential hypertension.

Key facts

Study ID

NCT01415531

Run by

Forest Laboratories

People needed

641

Starts

2011-08-01

Expected to finish

2012-04-01

Last updated by the study team

2013-05-16

Who can join

Age: 18 and older, up to 54. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female outpatients, of age 18 - 54 years
• Patients diagnosed with stage 1 or stage 2 essential hypertension
• Normal physical examination findings and electrocardiogram (ECG) results or abnormal findings judged by the Investigator to be not clinically significant

You may not qualify if…

• Secondary hypertension or severe hypertension
• History of Type 1 diabetes mellitus
• A medical contraindication to discontinuing a current antihypertensive therapy
• Clinically significant respiratory disease that prohibit use of a beta blocker

Where it is running

• Forest Investigative Site 067 — Phoenix, Arizona, United States
• Forest Investigative Site 070 — Phoenix, Arizona, United States
• Forest Investigative Site 049 — Buena Park, California, United States
• Forest Investigative Site 034 — Burbank, California, United States
• Forest Investigative Site 039 — Costa Mesa, California, United States
• Forest Investigative Site 024 — Fountain Valley, California, United States
• Forest Investigative Site 020 — Fresno, California, United States
• Forest Investigative Site 021 — Fresno, California, United States
• Forest Investigative Site 040 — Greenbrae, California, United States
• Forest Investigative Site 047 — La Mesa, California, United States
• Forest Investigative Site 073 — Los Angeles, California, United States
• Forest Investigative Site 077 — Roseville, California, United States
• Forest Investigative Site 060 — San Bernardino, California, United States
• Forest Investigative Site 054 — San Francisco, California, United States
• Forest Investigative Site 018 — Spring Valley, California, United States
• Forest Investigative Site 028 — Denver, Colorado, United States
• Forest Investigative Site 059 — Brooksville, Florida, United States
• Forest Investigative Site 033 — Fort Lauderdale, Florida, United States
• Forest Investigative Site 006 — Hallandale, Florida, United States
• Forest Investigative Site 044 — Longwood, Florida, United States
• Forest Investigative Site 001 — Miami, Florida, United States
• Forest Investigative Site 012 — Miami, Florida, United States
• Forest Investigative Site 032 — Miami, Florida, United States
• Forest Investigative Site 055 — Miami, Florida, United States
• Forest Investigative Site 065 — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.